PDYN Gene - Prodynorphin
Comprehensive genomic and functional analysis of the PDYN gene, encoding the opioid peptide precursor prodynorphin.
Gene Information Card
| Symbol | PDYN |
|---|---|
| Full Name | Prodynorphin |
| Gene Type | protein-coding |
| Chromosomal Location | 20p13 |
| NCBI Gene ID | 5173 ncbi.nlm.nih.gov/gene/5173 |
| Ensembl ID | ENSG00000101210 |
| UniProt ID | P01213 |
| OMIM ID | 131340 |
| HGNC ID | 8820 |
| Aliases | DYN, PENK, proenkephalin-B |
Description
The PDYN gene encodes prodynorphin, a precursor protein that is cleaved to produce several opioid peptides, including dynorphin A, dynorphin B, and alpha/beta-neoendorphin. These peptides act primarily on kappa-opioid receptors and are involved in pain modulation, stress response, addiction, and mood regulation.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Substance use disorders | Altered dynorphin signaling affects reward pathways and stress response | OMIM #131340; ClinVar |
| Schizophrenia | Dysregulation of prodynorphin expression in prefrontal cortex | NCBI Gene; PubMed |
| Epilepsy | Dynorphin peptides modulate seizure susceptibility via kappa-opioid receptors | OMIM; PubMed |
| Chronic pain | Imbalance in dynorphin levels contributes to pain sensitization | UniProt; PubMed |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain (cerebral cortex) | 12.5 | Medium |
| Spinal cord | 8.3 | Medium |
| Adrenal gland | 6.1 | Low |
| Testis | 3.2 | Low |
| Pituitary gland | 2.8 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (neuroblastoma) | 5.4 | Neuronal model |
| U-87 MG (glioblastoma) | 2.1 | Low expression |
| HEK293 (embryonic kidney) | 0.3 | Very low |
| HepG2 (hepatocellular carcinoma) | 0.1 | Not detected |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| rs1997794 (c.36C>T) | SNP | 0.15 (global) | Alters prodynorphin processing; associated with substance dependence |
| rs1022563 (c.72G>A) | SNP | 0.08 (global) | Linked to schizophrenia risk |
| rs2235749 (c.96T>C) | SNP | 0.12 (global) | Associated with epilepsy susceptibility |
Mutation functional classification
Loss of Function (LOF)
Rare nonsense or frameshift variants leading to truncated prodynorphin; not well documented in population databases.
Gain of Function (GOF)
Not reported; no known gain-of-function mutations in PDYN.
Dominant Negative (DN)
Not reported; no evidence for dominant-negative effects.
View complete mutation data:
Gene Ontology (GO)
Pathways
• KEGG: hsa05032 – Morphine addiction
• KEGG: hsa04080 – Neuroactive ligand-receptor interaction
• Reactome: R-HSA-375276 – Peptide ligand-binding receptors
Protein Summary
Prodynorphin (UniProt P01213) is a 254-amino-acid precursor protein that undergoes proteolytic cleavage to generate multiple opioid peptides, including dynorphin A (1-17), dynorphin B (1-13), and neoendorphins. These peptides are endogenous ligands for kappa-opioid receptors and play key roles in pain perception, stress, and reward. The protein is predominantly expressed in the central nervous system and adrenal medulla.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PDYN Knockout HCT 116 Cell Line | EDJ-KQ71075 | Human | 5173 | Details Get a Quote |
| PDYN Knockout A-549 Cell Line | EDJ-KQ62602 | Human | 5173 | Details Get a Quote |
| PDYN Knockout HeLa Cell Line | EDJ-KQ54114 | Human | 5173 | Details Get a Quote |
| PDYN Knockout HEK293 Cell Line | EDJ-KQ3125 | Human | 5173 | Details Get a Quote |